Immortalized Human Adipose-derived Stromal Cells – Bmi-1/hTERT

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Immortalized Cells

Tissue Type

Adipose

Organism

Human (H. sapiens)

Donor History

Female

,

30

Growth Properties

Adherent

,

polygonal

Growth Conditions
Immortalization Method

Serial passaging and transduction with recombinant lentiviruses carrying mouse Bmi-1 (pLOX-CWBmi1) [Ref. seq.: NM_007552.4] and hTERT (pLOX-TERT-iresTK) [Ref.seq.: NM_198253.2] gene

Full Information

https://www.abmgood.com/immortalized-human-adipose-derived-stromal-cells-bmi-1-htert.html

Katalogové číslo: T0540 Kategorie: ,
Popis

With its ability to maintain multipotency, mesenchymal stem cells provide new venues for cell-based therapy in restoration of damaged or diseased tissue. Most clinical studies utilize bone marrow-derived stem cells, however adipose-derived stromal cells (ASCs) is emerging as an alternative source for their ease of harvesting. The Immortalized Adipose-derived Stromal Cells- Bmi-1/hTERT is derived from human ASCs that have maintained their primary phenotypes and their ability to respond to osteogenic and adipogenic inductions. After 3 weeks of induced osteogenic differentiation, the immortalized ASCs show nuclear translocation of RUNX2, upregulation of alkaline phosphatase and calcium deposition. Furthermore, the immortalized ASCs-Bmi-1/hTERT exhibit normal karyotype and has been shown to exceed 140 population doublings, making these cells suitable for studies in regenerative medicine. Real Time PCR, immunofluorescence, and telemorase activity was used to quantify Bmi-1 and/or hTERT gene expression in the immortalized cell line.

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.